GSK Begins Shipping Fluviral Ahead of Canada’s 2025–26 Flu Season
GSK Canada (GlaxoSmithKline Inc.) has started shipping its trivalent seasonal influenza vaccine, Fluviral, to provinces across the country in preparation for the 2025–26 flu season.
Protecting Canadians Against Influenza
Fluviral is approved for use in adults and children over six months of age.
It protects against influenza virus types A and B included in the vaccine.
Annual vaccination remains the most effective way to reduce flu risks, according to Health Canada.
Each year, influenza leads to:
- 12,000+ hospitalizations
- 3,500 deaths
- Ranking among Canada’s top 10 leading causes of death.
The Public Health Agency of Canada recommends yearly vaccination for everyone six months and older, unless contraindicated.
Made in Quebec for Canadians
Fluviral is manufactured at GSK’s Ste-Foy, Quebec facility, which has supplied Canadians with flu vaccines since 1997.
The site produces the majority of Canada’s seasonal flu vaccine supply.
In the event of a pandemic, it serves as the country’s primary supplier of influenza vaccine.
2025–26 WHO Strain Recommendations
Each year, the World Health Organization (WHO) reviews circulating strains and recommends vaccine composition.
For egg-based vaccines in the Northern Hemisphere (2025–26), WHO advised including:
Fluviral’s composition for this season follows these recommendations.
Who Is at Higher Risk?
Although anyone can get the flu, complications are more common in:
Children under six
Adults 65+
Indigenous Peoples
Pregnant women
People in congregate care settings
Individuals with chronic conditions such as asthma, diabetes, or heart disease
About Fluviral
Type: Trivalent, split-virion influenza vaccine
Use: Active immunization against influenza A and B
Age group: Adults and children over six months
GSK’s Broader Mission
GSK describes its purpose as uniting science, technology, and talent to get ahead of disease together.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!